Latest news for Valneva (OTC:INRLF) Stock

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE

Valneva

News

INRLF

Valneva Announces HSR Clearance For Lyme Vaccine Collaboration With Pfizer

Intraday Update

Markets

Movers

Trading Ideas

AAGC

AAGIY

AAWC

ABCE

ABNAF

ABVC

ACAM

ACCA

ACCR

ACMC

ACRFF

AERG

AERO

AFPW

AGFAF

AGHI

AGLDF

AHELF

AINSF

AIRT

ALAN

ALPE

ALPP

ALST

AMBS

AMHPF

AMMX

AMPG

ANTH

ANXGF

APAFF

APHD

APNHY

ARAFF

AREB

ARRRF

ARYC

ARZTY

ASNT

ATDS

ATHOF

AUOTY

AVBH

AVOI

AVVH

AXTG

BABB

BANJ

BAYK

BBAVY

BBKCF

BBRRF

BCCI

BCCLF

BDVB

BEPTF

BIOIF

BIPH

BIXT

BKIRF

BKRKF

BKRKY

BLAGF

BLIAQ

BMRK

BNCC

BOLYY

BONTQ

BOTJ

BREUF

BRGGF

BRLXF

BRPHF

BRUZF

BRYN

BRZL

BSCA

BSGC

BTTR

BXNG

BXRX

BYOC

CALB

CAWW

CBAN

CBAT

CBDL

CBMJ

CBYAA

CCCGY

CCLAF

CCOHY

CDTI

CDUAF

CELZ

CESDF

CGNH

CGOL

Stocks That Hit 52-Week Lows On Tuesday

Comments

Valneva

News

Latest news for Valneva (OTC:INRLF) Stock

Monday, June 08, 2020

Tuesday, March 24, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga